Menu

More Women at the Top

One program's success in preparing and sustaining women for leadership in the sciences.

Aug 1, 2008
Katharine A. Gleason, Rosalyn C. Richman, Page S. Morahan

While women are entering the sciences and health professions in record numbers, the percentage that achieves positions of leadership lags far behind that of male scientists. This deficit of high-ranking female science leaders represents both a business and equity issue. Diversity, including gender diversity, has come to be recognized as an essential component in the development and maintenance of strong, creative, and competitive organizations. This is achieved not through tokenism but by the presence of a "critical mass" of women and other minorities in leadership roles.1

An increasing number of programs address the "pipeline" issue - ensuring that there are capable, qualified women and minority scientists in entry-level positions.2 Several programs - the National Science Foundation Advance Program, the Association of American Medical Colleges' (AAMC) Early- and Mid-Career Faculty Seminars, and MentorNet for female engineers - have been successful in training and supporting women at the beginning to midlevel stages of their careers.

Unfortunately, the pipeline leaks. At every step from postdoc on up, women trickle away at rates that far exceed those of their male counterparts. The reasons for these leaks are complex and varied, ranging from outright discrimination, such as unequal compensation, to much more subtle policies and social norms that are biased against the roles that women traditionally play. For example, some tenure policies disregard or minimize the impact of childbirth/adoption on short-term productivity; moreover, there is an under-appreciation for the time and energy of women who often focus on teaching and mentoring.

Few programs address the leaks as women progress at midcareer level and beyond. One is the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program for Women, within the Institute for Women's Health and Leadership at Drexel University College of Medicine. When ELAM welcomed its first class in 1995, it was a trailblazer and is now viewed by many as a virtual prerequisite for women aspiring to high-level leadership positions in academic health centers.

In addition to the widespread belief that participation in the ELAM program is highly beneficial to a woman's career, there is a growing body of evidence to demonstrate that ELAM works at the institutional level as well.

First, there are the statistics. ELAM alumnae currently represent nearly 30% of the female deans of schools of medicine, dentistry, and public health in the United States and Canada. About 25% of ELAM graduates hold a variety of high-level positions in university administration, industry, foundations, and organizations. Additionally, from its inception ELAM has emphasized rigorous research and impact evaluation. In a longitudinal study, ELAM graduates were compared with a matched cohort of women from the Association of American Medical Colleges' Faculty Roster and with a group of women who applied but were not accepted into the AAMC program. ELAM graduates scored higher on 15 of 16 leadership indicators than did the women in the other two groups; for 12 of the 15 indicators, the difference was significant.3

In a recent survey of deans at medical and dental schools in the United States and Canada, the deans perceived ELAM graduates to be a positive addition to their institution, to have benefited personally from the program, and to be highly promotable. Finally, intensive longitudinal interviews are developing new theory on the way women learn leadership.

The ELAM Program has achieved this high level of success by maintaining a steady focus on its three principal goals: to advance women to leadership positions, to support and sustain women who attain leadership positions, and ultimately to change the culture of academic health care so that the contributions of women are recognized and valued.

The authors are at the ELAM Program, Drexel University College of Medicine, Philadelphia. Program information: www.drexelmed.edu/ELAM.

References

1. R.M. Kanter, Men and Women of the Corporation, New York: Basic Books, 1993. 2. P. Leboy, "Fixing the leaky pipeline," The Scientist, 22(1), 67, 2008. 3. S.A. Dannels et al., "Evaluating a leadership program: A comparative, longitudinal study to assess the impact of the executive leadership in academic medicine (ELAM) program for women," Acad Med, May 2008.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Preparing Cell Or Tissue Lysates For ELISA Kits

Preparing Cell Or Tissue Lysates For ELISA Kits

RayBiotech manufactures over 2,000 high fully validated, GMP-compliant ELISA kits. In this blog post we explain how to prepare cell or tissue lysates for ELISA Kits.

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it has become Propel-Certified through Illumina as a Next Generation Sequencing (NGS) service provider.

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.